Ischemic disease
Pro Research Analysisby 
Searched over 200M research papers for "ischemic disease"
Consensus Meter
Understanding Ischemic Disease: Insights from Recent Research
Global Burden and Risk Factors of Ischemic Stroke
Ischemic stroke (IS) is a major neurovascular condition caused by the thrombosis of cerebral blood vessels, leading to brain ischemia. It is a significant cause of death and disability worldwide. Recent studies have highlighted the increasing global burden of IS, with deaths rising from 2.04 million in 1990 to 3.29 million in 2019, and projections indicating a further increase to 4.90 million by 2030. Key risk factors contributing to this burden include smoking, high body mass index (BMI), high systolic blood pressure, high low-density lipoprotein cholesterol, kidney dysfunction, high fasting plasma glucose, and high sodium diet. These findings underscore the need for targeted preventive strategies to mitigate the impact of these risk factors, especially in low socio-demographic index regions.
Mechanisms of Ischemia/Reperfusion Injury
Ischemia/reperfusion (I/R) injury is a critical aspect of ischemic diseases, including myocardial infarction, stroke, and peripheral vascular disease. The extent of tissue damage is directly related to the reduction in blood flow and the duration of ischemia, which leads to decreased ATP levels and intracellular pH, causing calcium overload and cell death . Reperfusion, while necessary to restore oxygen supply, paradoxically exacerbates tissue injury through the production of reactive oxygen species, inflammatory responses, and mitochondrial dysfunction . Understanding these mechanisms is crucial for developing therapeutic approaches that target multiple pathological processes to enhance tissue repair and reduce cell death.
Ischemic Heart Disease: Trends and Mortality
Ischemic heart disease (IHD) remains the leading cause of mortality globally, with significant variations in death rates across different countries. Analysis of mortality data from 2005 to 2015 shows a progressive decline in IHD mortality in countries like the United States, United Kingdom, and Brazil, attributed to reductions in smoking and hypertension. However, the rise in obesity and type II diabetes poses new challenges for future improvements in IHD outcomes. These trends highlight the importance of continuous monitoring and addressing emerging risk factors to sustain the decline in IHD mortality.
Genetic Factors in Ischemic Stroke
Genetic predisposition plays a significant role in the susceptibility to ischemic stroke. The ANRIL locus on chromosome 9p21 has been associated with IS risk, with specific single-nucleotide polymorphisms (SNPs) showing significant correlations with the disease. Meta-analyses have identified SNPs such as rs10757274, rs10757278, and rs1333040 as being particularly relevant, with variations in their impact across different ethnic groups. These findings suggest that genetic screening could be valuable in identifying individuals at higher risk for IS and tailoring preventive measures accordingly.
Role of the Neurovascular Unit in Ischemic Stroke
The neurovascular unit (NVU) plays a critical role in the pathophysiology and recovery of ischemic stroke. The NVU, which includes endothelial cells, astrocytes, neurons, and extracellular matrix components, is essential for maintaining the blood-brain barrier and facilitating neurovascular repair. Recent research has emphasized the importance of targeting the NVU in developing new therapeutic strategies for IS, focusing on enhancing blood-brain barrier integrity, reducing inflammation, and promoting cell survival and repair.
Metabolic Changes in Cerebral Ischemia
Cerebral ischemia triggers complex metabolic disturbances that contribute to brain tissue damage and neuronal cell death. Studies using metabolome-based techniques have identified significant changes in amino acids, organic acids, and polyamines in ischemic brain tissue, providing insights into the cellular pathologies of ischemic stroke. These metabolic alterations can serve as potential biomarkers for diagnosing and monitoring the progression of ischemic stroke, as well as targets for therapeutic intervention.
Conclusion
Ischemic diseases, including ischemic stroke and ischemic heart disease, continue to pose significant health challenges globally. Understanding the risk factors, genetic predispositions, and underlying mechanisms of ischemia and reperfusion injury is crucial for developing effective preventive and therapeutic strategies. Advances in genetic research, neurovascular studies, and metabolomics offer promising avenues for improving the diagnosis, treatment, and management of ischemic diseases, ultimately reducing their global burden.
Sources and full results
Most relevant research papers on this topic